---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-007716"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:56:41.693180+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# agilon health Q4 revenue up 44% to $1.52B; net loss narrows to $106M; guides 2025 EBITDA loss improvement

## Summary
- Q4 revenue $1.52B (+44% YoY); full-year revenue $6.06B (+40%). Medicare Advantage members 527,000 (+36%).
- Q4 net loss $106M (vs $230M loss in Q4 2023); full-year net loss $260M (vs $263M). Adjusted EBITDA loss $84M (Q4) and $154M (FY).
- Medical margin improved to $1M in Q4 from negative $102M; FY medical margin $205M vs $299M. Gross profit negative $38M.
- 2025 guidance: revenue $5.825-6.025B; medical margin $275-325M; Adjusted EBITDA loss $95-55M. Expects elevated cost trend of 6.3% (gross) vs 6.8% in 2024.
- Exiting partnerships affecting ~54,000 members; Class of 2025 adds ~20,000 MA members. Part D exposure reduced to <30%.

## SEC filing metadata
- accession: 0001628280-25-007716
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828025007716/0001628280-25-007716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828025007716/agl-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-007716
- JSON: https://secwatch.observer/filing/0001628280-25-007716.json
- Plain text: https://secwatch.observer/filing/0001628280-25-007716.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.